KLKihyun Lee

Kihyun Lee

*This is an algorithmically generated author record based on publicly available information.

Kihyun Lee has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genome-Level Hierarchical Attention Transformer with Multi-Head Attention Weighted Sum for Broad-Spectrum Antimicrobial Resistance Prediction and Discovery of Resistance-Related Genomic Contexts

    by Sein Park, Hyounggyu Kim, Kihyun Lee, Hyun-Seok Oh

    Antimicrobial resistance is a growing global health concern, requiring reliable tools for predicting resistance across a wide range of bacteria and antibiotics. In this study, we introduce a genome-level hierarchical attention transformer (GL-HAT) that integrates a pretrained genomic foundation model with hierarchical attention mechanisms to analyze the full protein sequence context of bacterial genomes. GL-HAT is designed to deliver both accurate resistance predictions and interpretable insights into the genomic features associated with resistance using specialized modules. Trained and validated on a comprehensive dataset of bacterial genomes and antimicrobial susceptibility profiles, the model outperformed traditional machine learning method, with an F1-score of 0.845 and AUROC of 0.953. Moreover, GL-HAT could demonstrate the resistance-related contexts in the genome, such as vanA operon and nearby resolvase genes in vancomycin-resistant Enterococcus and tet(M) gene adjacent to conjugation proteins in tetracycline-resistant Streptococcus pneumoniae. By combining high accuracy with interpretability, GL-HAT offers a practical approach for advancing AMR diagnostics and research, supporting more informed clinical and public health decisions.

  • Top Cited Papers
    Open Access

    EzBioCloud: a genome-driven database and platform for microbiome identification and discovery

    by Mauricio Chalita, Yeong Ouk Kim, Sein Park, Hyun-Seok Oh, Jae Hyoung Cho, Jeongsup Moon, Nuga Baek, Changsik Moon, Kihyun Lee, Junwon Yang, et al.

    With the continued evolution of DNA sequencing technologies, the role of genome sequence data has become more integral in the classification and identification of Bacteria and Archaea. Six years after introducing EzBioCloud, an integrated platform representing the taxonomic hierarchy of Bacteria and Archaea through quality-controlled 16S rRNA gene and genome sequences, we present an updated version, that further refines and expands its capabilities. The current update recognizes the growing need for accurate taxonomic information as defining a species increasingly relies on genome sequence comparisons. We also incorporated an advanced strategy for addressing underrepresented or less studied lineages, bolstering the comprehensiveness and accuracy of our database. Our rigorous quality control protocols remain, where whole-genome assemblies from the NCBI Assembly Database undergo stringent screening to remove low-quality sequence data. These are then passed through our enhanced identification bioinformatics pipeline which initiates a 16S rRNA gene similarity search and then calculates the average nucleotide identity (ANI). For genome sequences lacking a 16S rRNA sequence and without a closely related genomic representative for ANI calculation, we apply a different ANI approach using bacterial core genes for improved taxonomic placement (core gene ANI, cgANI). Because of the increase in genome sequences available in NCBI and our newly introduced cgANI method, EzBioCloud now encompasses a total of 109 835 species, of which 21 964 have validly published names. 47 896 are candidate species identified either through 16S rRNA sequence similarity (phylotypes) or through whole genome ANI (genomospecies), and the remaining 39 975 were positioned in the taxonomic tree by cgANI (species clusters). Our EzBioCloud database is accessible at www.ezbiocloud.net/db.


  • Top Cited Papers
    Open Access

    Population-level impacts of antibiotic usage on the human gut microbiome

    by Kihyun Lee, Sebastien Raguideau, Kimmo Sirén, Francesco Asnicar, Fabio Cumbo, Falk Hildebrand, Nicola Segata, Chang-Jun Cha, Christopher Quince

    The widespread usage of antimicrobials has driven the evolution of resistance in pathogenic microbes, both increased prevalence of antimicrobial resistance genes (ARGs) and their spread across species by horizontal gene transfer (HGT). However, the impact on the wider community of commensal microbes associated with the human body, the microbiome, is less well understood. Small-scale studies have determined the transient impacts of antibiotic consumption but we conduct an extensive survey of ARGs in 8972 metagenomes to determine the population-level impacts. Focusing on 3096 gut microbiomes from healthy individuals not taking antibiotics we demonstrate highly significant correlations between both the total ARG abundance and diversity and per capita antibiotic usage rates across ten countries spanning three continents. Samples from China were notable outliers. We use a collection of 154,723 human-associated metagenome assembled genomes (MAGs) to link these ARGs to taxa and detect HGT. This reveals that the correlations in ARG abundance are driven by multi-species mobile ARGs shared between pathogens and commensals, within a highly connected central component of the network of MAGs and ARGs. We also observe that individual human gut ARG profiles cluster into two types or resistotypes. The less frequent resistotype has higher overall ARG abundance, is associated with certain classes of resistance, and is linked to species-specific genes in the Proteobacteria on the periphery of the ARG network.


  • Open Access

    Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets

    by Gun-Ha Kim, Kihyun Lee, Jung Ok Shim

    Research on the gut bacteria in irritable bowel syndrome (IBS) shows discordant results due to inconsistent study designs or small sample sizes. To overcome these issues, we analyzed microbiota of 567 IBS patients and 487 healthy people from 10 shared data sets using a unified method.


  • Investigation of the effect of pre-fill gas in VEST discharges by predictive transport simulations

    by Chan-Young Lee, SeongCheol Kim, Young-Gi Kim, YooSung Kim, Kihyun Lee, Y. S. Hwang, Yong-Su Na


  • Open Access

    Epidemiologic Linkage of COVID-19 Outbreaks at Two University-affiliated Hospitals in the Seoul Metropolitan Area in March 2020

    by Kuenyoul Park, Jaewoong Lee, Kihyun Lee, Jiwon Jung, Sung-Han Kim, Jina Lee, Mauricio Chalita, Seok-Hwan Yoon, Jongsik Chun, Kyu-Hwa Hur, et al.

    Park K, et al. J Korean Med Sci. 2021 Jan;36(4):e38. https://doi.org/10.3346/jkms.2021.36.e38


  • Open Access

    Gut Bacterial Dysbiosis in Children with Intractable Epilepsy

    by Kihyun Lee, Namil Kim, Jung Ok Shim, Gun-Ha Kim

    A few published clinical studies have evaluated the association between gut microbiota in intractable epilepsy, but with inconsistent results. We hypothesized that the factors associated with the gut bacterial composition, such as age and geography, contributed to the discrepancies. Therefore, we used a cohort that was designed to minimize the effects of possible confounding factors and compared the gut microbiota between children with intractable epilepsy and healthy controls. Eight children with intractable epilepsy aged 1 to 7 years and 32 age-matched healthy participants were included. We collected stool samples and questionnaires on their diet and bowel habits at two time points and analyzed the gut microbiota compositions. In the epilepsy group, the amount of Bacteroidetes was lower (Mann–Whitney test, false discovery rate (FDR) < 0.01) and the amount of Actinobacteria was higher (FDR < 0.01) than in the healthy group. The epilepsy subjects were 1.6- to 1.7-fold lower in microbiota richness indices (FDR < 0.01) and harbored a distinct species composition (p < 0.01) compared to the healthy controls. Species biomarkers for intractable epilepsy included the Enterococcus faecium group, Bifidobacterium longum group, and Eggerthella lenta, while the strongest functional biomarker was the ATP-binding cassette (ABC) transporter. Our study identified gut bacterial dysbiosis associated with intractable epilepsy within the cohort that was controlled for the factors that could affect the gut microbiota.